Skip to main content
OpenTrials

Clinical trial discovery

Find Clinical Trials

Search studies by condition, treatment, location, eligibility, or trial identifier.

Showing 1–20 of 262 trials

Active filters

Clinical trials found

Published and searchable clinical trials

Searching for clinical trials...
Recruiting

Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

NCT03011814

Conditions
Folliculotropic Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Registry of Older Patients With Cancer

NCT01137825

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +98 more
Locations
  • Seby B. Jones Cancer Center Boone, North Carolina, United States
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
  • East Carolina University Greenville, North Carolina, United States
  • Pardee Cancer Center Hendersonville, North Carolina, United States
View Trial Details
Recruiting

A Registry for People With T-cell Lymphoma

NCT05978141

Conditions
Adult T-Cell Leukemia/Lymphoma, Aggressive NK-cell Leukemia, Anaplastic Large Cell Lymphoma, ALK-Positive, +54 more
Locations
  • City of Hope Cancer Center (Data collection only) Duarte, California, United States
  • UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only) San Diego, California, United States
  • University of California San Francisco (Data collection only) San Francisco, California, United States
  • Stanford University Medical Center (Data collection only) Stanford, California, United States
View all 26 locations
View Trial Details
Recruiting

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

NCT06854653

Conditions
CTCL, Disease Attributes, Hemic and Lymphatic Diseases, +15 more
Locations
  • City of Hope Comprehensive Cancer Cente Duarte, California, United States
  • University of California Irvine Irvine, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 15 locations
View Trial Details
Recruiting

Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

NCT03587844

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Recruiting

Extracorporeal Photopheresis in Sezary Syndrome

NCT05157581

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Cutaneous Translational Research Program - Johns Hopkins Medicine Baltimore, Maryland, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma

NCT06588868

Conditions
Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome, +13 more
Locations
  • AOU Ospedali Riuniti delle Marche - Clinica di Ematologia Ancona, Italy
  • IRCCS Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia Bari, Italy
  • U.O.C. Dermatologia e Venereologia Universitaria - A.O.U. Policlinico Consorziale Bari, Italy
  • Policlinico S.Orsola-Malpighi - Istituto di Ematologia Bologna, Italy
View all 18 locations
View Trial Details
Recruiting

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

NCT04234048

Conditions
Angioimmunoblastic T-cell Lymphoma, Cutaneous T-Cell Lymphoma, Cutaneous T-Cell Lymphoma, Unspecified, +23 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • City of Hope Medical Foundation Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
View Trial Details
Recruiting

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

NCT07003100

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +19 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
View Trial Details
Not Yet Recruiting

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

NCT07192471

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations
  • University of California, Irvine Medical Center - Hematology/Oncology Orange, California, United States
  • Stanford University School of Medicine Stanford, California, United States
  • Beth Israel Deaconess Medical Center - Research Boston, Massachusetts, United States
  • Washington University School of Medicine - Oncology Hospital - Public St Louis, Missouri, United States
View all 17 locations
View Trial Details